期刊
FERTILITY AND STERILITY
卷 103, 期 4, 页码 923-U91出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.fertnstert.2014.12.114
关键词
Antimullerian hormone; antral follicle count; IVF clinic; multicenter randomized controlled trial; ovarian response
资金
- Merck Serono
- Ferring
- Beckman Coulter
- Wellcome Trust
- Medical Research Council (UK)
- UK Clinical Research Collaboration
- National Institutes of Health
- Chief Scientist Office (Scotland)
Objective: To compare antimullerian hormone (AMH) and antral follicle count (AFC) as predictors of ovarian response to controlled ovarian stimulation at individual fertility clinics. Design: Retrospective analysis of individual study center data in two multicenter trials. Centers that provided > 10 patients were included in the analysis. Setting: A total of 19 (n = 519 patients) and 18 study centers (n = 686 patients) participating in a long GnRH agonist trial (MERIT) and a GnRH antagonist trial (MEGASET), respectively. Patient(s): Infertile women of good prognosis. Intervention(s): Long GnRH agonist or GnRH antagonist cycles. Main Outcome Measure(s): Correlation between AMH and AFC, and oocyte yield by each study center for each trial. Results(s): Antimullerian hormone was more strongly correlated with oocyte yield than AFC: r = 0.56 vs. r = 0.28 in the GnRH agonist cohort, and r = 0.55 vs. r = 0.33 in the GnRH antagonist cohort. The correlation was numerically higher for AMH than for AFC at a significantly higher proportion of study centers: 17 (89%) and 15 (83%) centers in the long GnRH agonist and GnRH antagonist trial, respectively. Assessment of the relative capacity of AMH and AFC for predicting oocyte yield demonstrated that AMH dominated the model: AMH, R-2 = 0.29 and 0.23; AFC: R-2 = 0.07 and 0.07; AMH + AFC: R-2 = 0.30 and 0.23 for long GnRH agonist and GnRH antagonist trials, respectively. Conclusions(s): Antimullerian hormone was a stronger predictor of ovarian response to gonadotropin therapy than AFC at the study center level in both randomized trials utilizing GnRH agonist and GnRH antagonist protocols. Antral follicle count provided no added predictive value beyond AMH. (C) 2015 by American Society for Reproductive Medicine.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据